semaglutide
semaglutide is listed in the FDA National Drug Code directory with 79 NDC codes, marketed under brand names including Ozempic, WEGOVY, OZEMPIC. Available dosage forms: powder, injection, solution, tablet.
Drug details
- Generic Name
- semaglutide
- Brand Names
- Ozempic, WEGOVY, OZEMPIC
- Application Number
- NDA209637
- Sponsor
- Arene Life Sciences Private Limited
- NDC Codes
- 79
- Dosage Forms
- POWDER, INJECTION, SOLUTION, TABLET
- Routes
- SUBCUTANEOUS, ORAL
- Active Ingredients
- SEMAGLUTIDE
Indications and Usage
1 INDICATIONS AND USAGE OZEMPIC is indicated: • as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus. • to reduce the risk of major adverse cardiovascular events (cardiovascular death, non-fatal myocardial infarction or non-fatal stroke) in adults with type 2 diabetes mellitus and established cardiovascular disease. • to reduce the risk of sustained eGFR decline, end-stage kidney disease, and cardiovascular death in adults with type 2 diabetes mellitus and chronic kidney disease. OZEMPIC is a glucagon-like peptide 1 (GLP-1) receptor agonist indicated: • as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus. ( 1 ) • to reduce the risk of major adverse cardiovascular events in adults with type 2 diabetes mellitus and established cardiovascular disease. ( 1 ) • to reduce the risk of sustained eGFR decline, end-stage kidney disease and cardiovascular death in adults with type 2 diabetes mellitus and chronic kidney disease. ( 1 )